GLENMARK PHARMACEUTICALS S.A.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 36219
 
  
 
C07D HETEROCYCLIC COMPOUNDS 21141
 
  
 
C07K PEPTIDES 16120
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 887
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 268
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2165
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 297
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2204
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 1137

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0362,327 ANTI-TRKA ANTIBODIES WITH ENHANCED INHIBITORY PROPERTIES AND DERIVATIVES THEREOF FOR USE IN TREATING BONE ASSOCIATED PAINDec 07, 15Dec 21, 17[A61K, C07K]
2017/0350,886 EXPRESSION CONSTRUCTS AND METHODS FOR SELECTING HOST CELLS EXPRESSING POLYPEPTIDESMar 02, 15Dec 07, 17[C12P, C12N, G01N, C07K]
2017/0260,280 Antibodies that Bind to OX40 and Their UsesNov 10, 16Sep 14, 17[A61K, C07K]
2017/0253,671 Expression Constructs and Methods for Expressing Polypeptides in Eukaryotic CellsNov 17, 16Sep 07, 17[C12P, C12N, C07K]
2017/0218,087 ANTI-TRKA ANTIBODIES WITH ENHANCED INHIBITORY PROPERTIES AND DERIVATIVES THEREOFSep 14, 16Aug 03, 17[C07K]
2017/0145,115 Production of T cell retargeting hetero-dimeric immunoglobulinsJun 23, 16May 25, 17[C07K]
2017/0135,991 NANOPARTICULATE FORMULATION COMPRISING A mPGES-1 INHIBITORJul 31, 15May 18, 17[A61K]
2016/0346,234 TREATMENT OF RESPIRATORY DISORDERS USING ROR-GAMMA INHIBITORSMay 31, 16Dec 01, 16[A61K, G01N]
2015/0343,058 ANTIBODY FORMULATIONDec 18, 13Dec 03, 15[A61K, C07K]
2015/0239,991 PURIFICATION OF HETERO-DIMERIC IMMUNOGLOBULINSSep 25, 13Aug 27, 15[C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9855229 Treatment of respiratory disorders using ROR-gamma inhibitorsMay 31, 16Jan 02, 18[A61K, G01N]
9718817 Aryl and heteroaryl ether compounds as ROR gamma modulatorsApr 15, 15Aug 01, 17[C07D, C07C]
9682977 Bicyclic heteroaryl indole analogues useful as ROR gamma modulatorsDec 09, 14Jun 20, 17[C07D]
9683052 Hetero-dimeric immunoglobulinsMar 23, 12Jun 20, 17[C07K]
9683053 Hetero-dimeric immunoglobulinsJan 29, 14Jun 20, 17[C07K]
9532988 Pharmaceutical composition comprising a TRPA1 antagonist and an analgesic agentOct 14, 14Jan 03, 17[A61K, A01N]
9493563 Production of T cell retargeting hetero-dimeric immunoglobulinsNov 04, 14Nov 15, 16[C07K]
9474758 Thienopyrimidinedione derivatives as TRPA1 modulatorsFeb 12, 15Oct 25, 16[A61K, C07D]
9458173 Amides of 2-amino-4-arylthiazole compounds and their saltsJun 08, 13Oct 04, 16[C07D]
9439890 Triazolone compounds as mPGES-1 inhibitorsJun 19, 15Sep 13, 16[A61K, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0158,236 PHARMACEUTICAL COMPOSITION COMPRISING A TRPA1 ANTAGONIST AND A STEROIDAbandonedDec 18, 15Jun 09, 16[A61K]
2015/0183,885 ANTI-TRKA ANTIBODIES WITH ENHANCED INHIBITORY PROPERTIES AND DERIVATIVES THEREOFAbandonedDec 05, 14Jul 02, 15[A61K, C07K]
2015/0056,655 EXPRESSION CONSTRUCTS AND METHODS FOR EXPRESSING POLYPEPTIDES IN EUKARYOTIC CELLSAbandonedAug 06, 14Feb 26, 15[C12N, C07K]
2014/0364,445 PHARMACEUTICAL COMPOSITION COMPRISING A TRPA1 ANTAGONIST AND AN ANTICHOLINERGIC AGENTAbandonedDec 05, 12Dec 11, 14[A61K]
2014/0341,892 ANTI-ALPHA2 INTEGRIN ANTIBODIES AND THEIR USESAbandonedMay 19, 14Nov 20, 14[A61K, G01N, C07K]
2014/0294,824 ANTIBODIES THAT BIND TO OX40 AND THEIR USESAbandonedMar 21, 14Oct 02, 14[C07K]
2014/0286,934 HUMANIZED ANTIBODIES THAT BIND TO CD19 AND THEIR USESAbandonedJan 30, 14Sep 25, 14[C07K]
2014/0148,423 PHARMACEUTICAL COMPOSITION COMPRISING A TRPA1 ANTAGONIST AND A STEROIDAbandonedJul 23, 12May 29, 14[A61K]
2014/0107,113 PHARMACEUTICAL COMPOSITION COMPRISING A TRPA1 ANTAGONIST AND A BETA-2 AGONISTAbandonedJun 21, 12Apr 17, 14[A61K]
8623880 Fused pyrimidine-dione derivatives as TRPA1 modulatorsExpiredMar 17, 10Jan 07, 14[A61K, A01N, C07D]
2013/0344,064 ANTI-TRKA ANTIBODIES WITH ENHANCED INHIBITORY PROPERTIES AND DERIVATIVES THEREOFAbandonedJun 07, 13Dec 26, 13[A61K, C07K]
2013/0344,604 Expression CassetteAbandonedDec 05, 12Dec 26, 13[C12N]
8592398 2-amino-4-arylthiazole compounds as TRPA1 antagonistsExpiredDec 15, 11Nov 26, 13[A61K, A01N, C07D]
8575178 Isothiazolo-pyrimidinedione derivatives as TRPA1 modulatorsExpiredMar 22, 10Nov 05, 13[A61K, A01N, C07D]
2013/0203,778 PHARMACEUTICAL COMPOSITION COMPRISING A PYRIMIDINEONE DERIVATIVEAbandonedMar 21, 11Aug 08, 13[C07D]
8492568 Chromane derivatives as TRPV3 modulatorsExpiredMay 19, 09Jul 23, 13[A61K, C07D]
8487121 Chromane derivatives as TRPV3 modulatorsExpiredDec 16, 08Jul 16, 13[A61K, C07D]
2013/0084,285 TREATMENT WITH ANTI-ALPHA2 INTEGRIN ANTIBODIESAbandonedAug 23, 12Apr 04, 13[C07K]
8349846 Fused pyrimidine derivatives as TRPV3 modulatorsExpiredJan 07, 09Jan 08, 13[A61K]
8344010 Fused imidazole derivatives as TRPV3 antagonistExpiredDec 23, 09Jan 01, 13[A61K, C07D]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.